Saudi Arabia Catheters Market Overview
Market Size in 2024: USD 220.89 Million
Market Size in 2033: USD 402.69 Million
Market Growth Rate 2025-2033: 6.9%
According to IMARC Group's latest research publication, "Saudi Arabia Catheters Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The Saudi Arabia catheters market size reached USD 220.89 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 402.69 Million by 2033, exhibiting a growth rate (CAGR) of 6.9% during 2025-2033.
How AI is Reshaping the Future of Saudi Arabia Catheters Market
- Revolutionizing Catheter Design and Manufacturing: AI-powered computational modeling and machine learning algorithms are transforming catheter development through intelligent material selection, optimized design configurations, and predictive performance testing, reducing product development cycles by 30-35% while enhancing biocompatibility, flexibility, and antimicrobial properties that meet stringent Saudi Food and Drug Authority (SFDA) standards and international quality benchmarks.
- Enhancing Real-Time Procedural Guidance Systems: Advanced AI-integrated imaging technologies and augmented reality platforms are revolutionizing cardiovascular, neurovascular, and urology catheterization procedures through intelligent navigation assistance, automated vessel mapping, and precision positioning guidance, improving procedural success rates by 25-30% while reducing complications and radiation exposure for patients across Saudi hospitals and specialized cardiac centers.
- Optimizing Infection Prevention and Safety Protocols: Machine learning systems are transforming central line-associated bloodstream infection (CLABSI) prevention through predictive risk assessment, automated compliance monitoring, and intelligent alert systems, supporting Saudi Arabia's remarkable 48.8% annual reduction in CLABSI rates from 2021 to 2024—quadrupling the global average—and advancing Vision 2030 healthcare quality objectives across intensive care units nationwide.
- Improving Supply Chain Management and Inventory Optimization: AI-driven demand forecasting and logistics platforms are revolutionizing catheter procurement, distribution, and inventory management across hospitals, clinics, and ambulatory surgical centers, reducing stockout incidents by 20-25% while optimizing storage conditions and ensuring continuous availability of cardiovascular, urology, intravenous, neurovascular, and specialty catheters throughout Northern, Central, Western, Eastern, and Southern regions.
- Enabling Personalized Treatment Planning and Patient Monitoring: Artificial intelligence analytics are transforming patient care through customized catheter selection algorithms, procedural outcome prediction models, and continuous post-intervention monitoring systems, enabling clinicians to select optimal catheter types and sizes based on individual patient anatomy, condition severity, and risk factors while improving long-term outcomes and reducing readmission rates.
Grab a sample PDF of this report: https://www.imarcgroup.com/saudi-arabia-catheters-market/requestsample
Saudi Arabia Catheters Market Trends & Drivers:
Saudi Arabia's catheters market is experiencing robust growth driven by the Kingdom's rapidly aging population and escalating chronic disease burden, with over 7 million individuals living with diabetes, cardiovascular diseases accounting for 42% of total deaths, and rising cancer incidence requiring extensive catheter-based interventions. The Saudi medical devices market reached USD 6.29 billion in 2024 and is projected to reach USD 9.96 billion by 2034 at a 4.70% CAGR, with the broader healthcare sector receiving over USD 1.5 billion in Vision 2030 investments for digital health integration, telemedicine, and advanced medical technologies.
The expansion of healthcare infrastructure and surgical capabilities is accelerating catheter demand, with the Kingdom operating 24 surgical robots primarily in governmental hospitals, positioning Saudi Arabia as a technology leader in the Middle East. King Faisal Specialist Hospital's introduction of minimally invasive catheter-based bioresorbable stent techniques in April 2025 for peripheral artery disease treatment exemplifies the shift toward advanced catheterization procedures that reduce surgical complications and recovery times. The country's 35 accredited urology training centers across 18 cities and robust cardiac catheterization facilities are driving procedural volumes, while the 36th Saudi Urology Association Conference in February 2025 and continuous medical education programs strengthen clinical competencies in catheter-based interventions.
Saudi Arabia's remarkable success in infection control is transforming procurement preferences and quality standards, with the national healthcare initiative achieving a 48.8% annual reduction in central catheter-associated bloodstream infections (CLABSI) in ICUs from 2021 to 2024—quadrupling the WHO global average—through comprehensive training of over 5,000 healthcare practitioners. This achievement is driving demand for catheters with enhanced protective features, antimicrobial coatings, and advanced safety mechanisms. The Kingdom's international medical missions, including KSrelief cardiac catheterization programs that completed 166 catheterizations and 25 open-heart surgeries at Prince Mohammed bin Salman Hospital in Yemen during May 2024, are reinforcing domestic clinical expertise while showcasing Saudi leadership in regional healthcare delivery. Additionally, SFDA's June 2024 MDS-G010 guidance establishing regulatory requirements for AI- and machine learning-based medical devices is accelerating the integration of intelligent catheter technologies, smart sensors, and real-time monitoring capabilities aligned with the Kingdom's digital health transformation under Vision 2030.
Saudi Arabia Catheters Industry Segmentation:
The report has segmented the market into the following categories:
Product Type Insights:
- Cardiovascular Catheters
- Urology Catheters
- Intravenous Catheters
- Neurovascular Catheters
- Specialty Catheters
- Others
End User Insights:
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Others
Breakup by Region:
- Northern and Central Region
- Western Region
- Eastern Region
- Southern Region
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Recent News and Developments in Saudi Arabia Catheters Market
- April 2025: King Faisal Specialist Hospital introduced an advanced minimally invasive catheter-based artery stent technique for treating peripheral artery disease, utilizing bioresorbable stents inserted through the thigh that restore blood flow and dissolve naturally, significantly reducing surgical intervention requirements and long-term complications for patients.
- December 2025: Saudi Arabia achieved a remarkable 48.8% annual reduction in central catheter-associated bloodstream infections (CLABSI) in ICUs from 2021 to 2024, quadrupling the WHO global average, through a national strategy launched in 2022 that trained over 5,000 healthcare practitioners in infection control protocols aligned with Vision 2030 objectives.
- May 2024: KSrelief medical volunteers conducted 166 cardiac catheterizations and 25 open-heart surgeries at Prince Mohammed bin Salman Hospital in Aden, Yemen, as part of the Saudi Development and Reconstruction Program, demonstrating the Kingdom's commitment to regional healthcare support while strengthening domestic catheter-based intervention capabilities.
Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.
About Us:
IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-201971-6302
